A retrospective analysis of hand tapping as a longitudinal marker of disease progression in Huntington’s disease

被引:0
作者
Lucy M Collins
Stanley E Lazic
Roger A Barker
机构
[1] John van Geest Centre for Brain Repair,In Silico Lead Discovery
[2] Novartis Institutes for Biomedical Research,undefined
来源
BMC Neurology | / 14卷
关键词
Huntington’s disease; Biomarker; Hand tapping;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 237 条
[1]  
MacDonald ME(1993)A novel gene containing a trinucleotide repeat that is expanded and unstable on huntingtons-disease chromosomes Cell 72 971-983
[2]  
Ambrose CM(1988)Differential loss of striatal projection neurons in huntington disease Proc Natl Acad Sci U S A 85 5733-5737
[3]  
Duyao MP(2003)Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis Neurology 60 1615-1620
[4]  
Myers RH(2009)Biological and clinical manifestations of huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data Lancet Neurol 8 791-801
[5]  
Lin C(2011)Biological and clinical changes in premanifest and early stage huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis Lancet Neurol 10 31-42
[6]  
Srinidhi L(2001)Objective assessment of progression in huntington’s disease: a 3-year follow-up study Neurology 57 920-924
[7]  
Barnes G(2013)A novel cognitive-neurophysiological state biomarker in premanifest huntington’s disease validated on longitudinal data Sci Reports 3 1797-694
[8]  
Taylor SA(2012)Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early huntington’s disease J Neurol Neurosurg Psychiatry 83 687-53
[9]  
James M(2012)Potential endpoints for clinical trials in premanifest and early huntington’s disease in the TRACK-HD study: analysis of 24 month observational data Lancet Neurol 11 42-233
[10]  
Groot N(2013)Huntington’s disease: the past, present, and future search for disease modifiers Yale J Biol Med 86 217-142